Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma

Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma

BackgroundG protein subunit gamma 12 (GNG12) is observed in some types of cancer, but its role in osteosarcoma is unknown. This study hypothesized that GNG12 may be a potential biomarker and therapeutic target. We aimed to identify an association between GNG12 and osteosarcoma based on the Gene Expr...

Full description

Bibliographic Details
Main Authors: Jinghong Yuan, Zhao Yuan, Aifang Ye, Tianlong Wu, Jingyu Jia, Jia Guo, Jian Zhang, Tao Li, Xigao Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Immunology
Subjects:
osteosarcoma
GNG12
biomarker
therapeutic target
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.758845/full

Similar Items

Similar Items